Health insurance premiums in the United States have risen 78% between 2011 and 2024, according to a study published in JAMA Health Forum. The sharp increase has made coverage unaffordable for many, including healthcare professionals who have been compelled to stop getting coverage for themselves and their staff at private facilities.
The trend shows no sign of abating. Projections indicate that in 2027, premiums for employer-sponsored insurance plans are expected to jump by 8.2%, further squeezing businesses and workers. These escalating costs are likely to affect even organizations that have long focused on addressing the needs of underserved populations, such as Astiva Health, which specializes in Medicare Advantage plans for diverse communities.
The implications are significant. As premiums outpace wage growth, more Americans may forgo insurance, leading to delayed care, worse health outcomes, and higher emergency room costs. Employers, particularly small businesses, may struggle to maintain coverage offerings, potentially reducing hiring or shifting costs to employees. The healthcare sector itself faces a paradox: those who provide care are increasingly unable to afford it.
The JAMA study underscores a decades-long trend of rising healthcare costs driven by factors including administrative expenses, prescription drug prices, and an aging population. While the Affordable Care Act expanded coverage, it did not fully address underlying cost growth. The projected 8.2% increase for 2027 suggests that without intervention, the burden will continue to mount.
For industry stakeholders, the data highlights the urgent need for innovative solutions. Read More>> on how rising premiums are reshaping the healthcare landscape.
As a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences, BioMedWire provides access to a vast network of wire solutions through InvestorWire, along with article and editorial syndication to 5,000+ outlets. The platform also offers enhanced press release enhancement and social media distribution to millions of followers. As part of the Dynamic Brand Portfolio at IBN, BioMedWire connects clients with investors, journalists, and the public.
The surge in premiums is more than a statistic; it signals a growing affordability crisis that could undermine the nation’s health and economic stability. Without concerted efforts to curb costs, the 78% spike since 2011 may be a precursor to even greater challenges ahead.
